Insider · CIK 0001952720
Christopher Krawtschuk
Files at BLUE (bluebird bio, Inc.). First filing Dec 8, 2023, latest Dec 8, 2023.
In brief
Christopher Krawtschuk files SEC Form 4 as CFO at BLUE (bluebird bio, Inc.). Since Dec 8, 2023, Christopher Krawtschuk has reported 0 open-market buys worth $0 and 1 open-market sell worth $20k, the latest filed on Dec 8, 2023.
A track record needs three past buys with six months of prices behind them; Christopher Krawtschuk has 0, so none is measured yet.
The newest scored trade: sold $20k of BLUE on Dec 6, 2023, filed Dec 8, 2023, scored 2 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 2Weak | bluebird bio, Inc. | $20k 4,526 shares | -9% | - |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 6, 2023 | BLUE bluebird bio, Inc. | SOpen-market sale Common Stock10b5-1 | -4,526 | $4.52 | $20k | 45,474 | Dec 8, 2023 |
Questions about Christopher Krawtschuk
Answered from the filings on this page, as of the latest one.
Is Christopher Krawtschuk buying or selling?
Not in the last 12 months. Christopher Krawtschuk's latest open-market trade on SEC Form 4 was sold $20k of BLUE on Dec 6, 2023.
How did Christopher Krawtschuk's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher Krawtschuk has 0.
Where does Christopher Krawtschuk file Form 4?
Christopher Krawtschuk has filed Form 4 at BLUE (bluebird bio, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.